Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...

Adding subcutaneous sasanlimab to BCG improved recurrence-free survival in non–muscle-invasive bladder cancer, according to Dr. Petros Grivas.

Karen Eubanks Jackson has reshaped the conversation around breast cancer for Black women in America—and now, with the ASCO ...

The study adds to growing evidence that digital tools can maximize genetic counselors' limited time without patient harm.

A new FDA application for vepdegestrant offers hope for advanced breast cancer patients with ESR1 mutations, showcasing ...

Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL ...

New data from the IRAKLIA and IZALCO trials, presented at the 2025 ASCO Annual Meeting, demonstrate that subcutaneous ...

Tango Therapeutics rebounds with a stronger pipeline, renewed focus on PRMT5 inhibitors, and key data ahead despite past ...

Impact of bone marrow involvement in patients with peripheral T-cell lymphoma undergoing autologous stem cell transplant. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Early-onset colorectal cancer is more likely to be diagnosed in people of Black or Hispanic race/ethnicity and be at a later stage at diagnosis.

Innovent Biologics presents data from phase 1 PoC study of IBI363 to treat advanced NSCLC at 2025 ASCO: San Francisco Friday, June 6, 2025, 18:00 Hrs [IST] Innovent Biologics, Inc ...